₹526.9
4.9 (0.9%)![]()
We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.
Unlock Stock of the Month
T&C*
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 521.04 | Bullish |
| 10-DMA | 525.29 | Bullish |
| 20-DMA | 528.59 | Bearish |
| 50-DMA | 573.15 | Bearish |
| 100-DMA | 559.8 | Bearish |
| 200-DMA | 549.63 | Bearish |
%
Below figures are in Rs. Crores
| Particulars | Mar-2026 | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|---|
| Net Sales | 25,685 | 21,527 | 23,949 | 24,672 | 22,016 |
| Total Expenditure | 21,702 | 18,929 | 20,125 | 18,488 | 16,744 |
| Other Income | 1,410 | 1,276 | 1,417 | 1,091 | 795 |
| Operating Profit | 5,393 | 3,874 | 5,241 | 7,275 | 6,068 |
| Interest | 372 | 392 | 357 | 260 | 75 |
| Depreciation | 2,132 | 2,005 | 1,747 | 1,023 | 793 |
| Profit Before Tax | 4,044 | 1,651 | 3,954 | 6,774 | 5,605 |
| Consolidated Net Profit | 3,412 | 1,147 | 3,117 | 5,324 | 4,310 |
| Adjusted EPS | 18 | 6 | 16 | 28 | 22 |
Below figures are in Rs. Crores
| Particulars | Sep-2024 | Dec-2024 | Mar-2025 | Jul-2025 | Sep-2025 |
|---|---|---|---|---|---|
| Sales | 1,70,754 | 1,35,936 | 1,28,552 | 1,22,189 | 1,05,161 |
| Expenses | 63,042 | 56,557 | 52,457 | 45,459 | 34,856 |
| Operating Profit | 1,07,712 | 79,379 | 76,096 | 76,730 | 70,304 |
| OPM % | 63% | 58% | 59% | 63% | 67% |
| Other Income | 33,912 | 31,759 | 27,333 | 24,879 | 18,947 |
| Interest | 77,780 | 58,584 | 59,248 | 62,137 | 53,713 |
| Depreciation | 2,345 | 1,681 | 1,385 | 1,277 | 1,221 |
| Profit Before Tax | 61,498 | 50,873 | 42,796 | 38,195 | 34,318 |
| Tax % | 25% | 25% | 26% | 29% | 35% |
| Net Profit | 46,149 | 38,151 | 31,857 | 27,296 | 22,446 |
| EPS in Rs | 83 | 69 | 58 | 50 | 42 |
Below figures are in Rs. Crores
| Particulars | Mar-2026 | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|---|
| Share Capital | 386 | 386 | 386 | 386 | 386 |
| Total Reserves | 47,193 | 44,152 | 43,873 | 42,423 | 38,750 |
| Long-Term Borrowings | --- | --- | --- | --- | --- |
| Total Non-Current Liabilities | 978 | 1,089 | 1,079 | 949 | 1,072 |
| Other Current Liabilities | 951 | 825 | 1,070 | 1,437 | 1,627 |
| Short Term Borrowings | 7,933 | 5,849 | 6,194 | 7,409 | 6,634 |
| Total Liabilities | 61,658 | 56,482 | 57,014 | 56,920 | 54,358 |
| Capital Work in Progress | 2,236 | 709 | 2,123 | 4,720 | 6,961 |
| Long Term Loans & Advances | 1,797 | 1,713 | 1,654 | 2,663 | 2,323 |
| Currents Investments | 4,027 | 3,931 | 3,236 | 1,237 | 6,689 |
| Short Term Loans and Advances | 4,431 | 656 | 688 | 493 | 2,357 |
| Total Current Assets | 28,934 | 24,566 | 26,298 | 28,525 | 31,349 |
| Total Assets | 61,658 | 56,482 | 57,014 | 56,920 | 54,358 |
| Adjusted Book Value | 247 | 231 | 229 | 1,109 | 1,014 |
Investment Calculator
| Symbol | Change% |
|---|---|
| SUMICHEM | 502.3(14%) |
| ZENSARTECH | 516.1(10%) |
| AEGISVOPAK | 257.43(10%) |
| ECLERX | 1488.8(7%) |
| KAYNES | 3333.8(6%) |
Get Your Portfolio Reviewed

Stay Updated with Our Market Newsletters